We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 0P20 market cap is 6.79B. The company's latest EPS is HUF 1.1347 and P/E is 39.66.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | |
| Total Revenue | 910k | 1.42M | 450k | 450k | 450k |
| Operating Income | -9.49M | -17.59M | -13.14M | -15.97M | -21.08M |
| Net Income | -8.01M | 26.09M | 12.69M | 133.53M | 171.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | |
| Total Assets | 1.82B | 3.61B | 5.17B | 5.31B | 5.48B |
| Total Liabilities | 2.85M | 4.57M | 4.96M | 10.04M | 8.76M |
| Total Equity | 1.82B | 3.6B | 5.17B | 5.3B | 5.47B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | HUF (HUF) | |
| Operating | -50.99M | 75.86M | -443.79M | -1.1B | -536.09M |
| Investing | -99k | -575k | -429k | N/A | N/A |
| Financing | 460.84M | 1.98B | 1.55B | N/A | N/A |
| Market Cap | 6.79B |
| Price to Earnings Ratio | 39.66 |
| Price to Sales Ratio | 15k |
| Price to Cash Ratio | 3.15 |
| Price to Book Ratio | 1.24 |
| Dividend Yield | - |
| Shares Outstanding | 150.81M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Nutex Befektetesi Nyrt |
| Address |
czir��ki street 24-32. building a. ii. em. 141 budapest |
| Website | https://www.nutex.hu |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
